← All stocks

PRECISION BIOSCIENCES INC

DTIL Net buying
CIK 0001357874 #3786 in the set updated 18 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.59M
$922.34K on a plan · $4.14M straight out of an exercise
Sold at will
$523.94K
15 of 80 sales
Net
−$3.47M
+$1.60M against sales at will

By person

21 insiders · 119 transactions
1.4×

Michael Amoroso holds only 1.4 times base salary in stock. $934.63K of shares against $650.88K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Amoroso last reported holding, valued at $3.84, the price Common Stock was last bought or sold at on the open market here, on 18 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
JANTZ DEREK
Chief Scientific Officer
$1.62M (17) scheduled
−$1.62M
4,055,174
$15.57M
+5.5%
KANE MATTHEW R.
President and CEO
$1.61M (15) scheduled
−$1.61M
2,024,438
$7.77M
+11.0%
THOMSON DAVID S.
Chief Operating Officer
$1.24M (7) scheduled
−$1.24M
111,513
$428.21K
+2,434%
FMR LLC entity
See Remark 1
$800.00K (1)
+$800.00K
3,738,248
$14.35M
venBio Global Strategic Fund, L.P. entity
Director
$800.00K (1)
+$800.00K
4,265,141
$16.38M
Amoroso Michael
President and CEO
$616.53K (11) scheduled
−$616.53K
243,392
$934.63K
Scimeca Dario
General Counsel and Secretary
$169.10K (13) scheduled
−$169.10K
56,457
$216.79K
SMITH J. JEFFERSON
Chief Research Officer
$122.59K (7) scheduled
−$122.59K
121,926
$468.20K
YAO TONY DUNG LING
Director
$100.03K (1)
+$100.03K
166,903
$640.91K
Buehler Kevin
Director
$63.32K (3)
+$63.32K
49,137
$188.69K
Germano Geno J
Director
$47.57K (3)
+$47.57K
44,883
$172.35K
List Alan
Chief Medical Officer
$45.73K (6)
−$45.73K
4,488
$17.23K
Kelly John Alexander
Chief Financial Officer
$209.27K (7)
$164.22K (4) scheduled
+$45.05K
125,883
$483.39K
Brown Melinda
Director
$43.13K (5)
+$43.13K
44,346
$170.29K
Heery Christopher
Chief Medical Officer
$30.02K (2)
+$30.02K
2,485
$9.54K
Frankel Stanley
Director
$26.11K (2)
+$26.11K
40,478
$155.44K
+80,856%
ANSARI ABID
Chief Financial Officer
144,401
$554.50K
+6,737%
Schinazi Raymond F
Director
93,048
$357.30K
Pire Shari Lisa
Director
35,028
$134.51K
Barton Shane
VP & Corporate Controller
27,502
$105.61K
Wadsworth Samuel C.
Director
4,202
$16.14K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 7,671,059 to 27,601,554 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Amoroso Michael
4 Nov 2024
President and CEO
Sell
3,012
$8.19
$24.67K
SMITH J. JEFFERSON
10 Jun 2024
Chief Research Officer
Sell
50
$11.79
$589.50
Amoroso Michael
2 May 2024
President and CEO
Sell
1,526
$10.32
$15.75K
List Alan
2 May 2024
Chief Medical Officer
Sell
290
$10.32
$2.99K
SMITH J. JEFFERSON
2 May 2024
Chief Research Officer
Sell
154
$10.32
$1.59K
List Alan
30 Apr 2024
Chief Medical Officer
Sell
238
$10.03
$2.39K
SMITH J. JEFFERSON
23 Jan 2024
Chief Research Officer
Sell
28,000
$0.37
$10.36K
List Alan
6 Mar 2023
Chief Medical Officer
Sell
9,473
$1.07
$10.14K
Scimeca Dario
6 Mar 2023
General Counsel and Secretary
Sell
12,172
$1.07
$13.02K
Amoroso Michael
17 Oct 2022
President and CEO
Sell
11,006
$1.32
$14.53K
Scimeca Dario
8 Jun 2022
General Counsel and Secretary
Sell
9,833
$2.06
$20.26K
JANTZ DEREK
8 Jun 2022
Chief Scientific Officer
Sell
18,849
$2.06
$38.83K
List Alan
27 Apr 2022
Chief Medical Officer
Sell
7,775
$2.10
$16.33K
JANTZ DEREK
17 May 2021
Chief Scientific Officer
Sell
20,000
$9.38
$187.60K
THOMSON DAVID S.
21 Jan 2021
Chief Operating Officer
Sell
10,000
$16.49
$164.90K

What was left out

Form 4 filings counted 235
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 27
Sales straight out of an exercise 38
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 11,715,028
Sales filed before the plan box existed 8
History held since 29 Mar 2019